Investors must take note of Pacific Biosciences of California Inc’s (PACB) performance last week, which was -12.57%.
Pacific Biosciences of California Inc (NASDAQ: PACB) on Monday, plunged -5.19% from the previous trading day, before settling in for the closing price of $1.54.